Información*
| Nombre | FEDERICO AVILA MORENO |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | PATOLOGÍA |
| Especialidad | CANCER |
| CVU | 121542 |
| Institución | |
|---|---|
| Dependencia | SECRETARIA GENERAL |
| Entidad | MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2025
- Cascade Testing Among Patients With Breast Cancer: Current Situation and Challenges in Latin America JCO Global Oncology
- Impact of mSWI/SNF epigenetic complexes on ionizing radiotherapy resistance in malignant diseases: A comprehensive view in oncology Life Sciences
- A Pilot Study: Contrasting Genomic Profiles of Lung Adenocarcinoma Between Patients of European and Latin American Ancestry International Journal of Molecular Sciences
- Patient-specific gene co-expression networks reveal novel subtypes and predictive biomarkers in lung adenocarcinoma npj Systems Biology and Applications
- SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1 Cancer Gene Therapy
- RNA and epigenetic editing: The new frontier in gene and cell therapy Molecular Therapy
- 2024
- Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy Molecular Therapy
- Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells Inflammation
- Driving CAR-T cells toward solid lung tumors Molecular Therapy: Oncology
- Novel engineered recombinant ACE2 reduces SARS-CoV-2-induced COVID-19 without cardiotoxic side effects Molecular Therapy